Published in Respir Res on February 10, 2010
The grand challenge to decipher the cancer proteome. Nat Rev Cancer (2010) 1.49
Lung Cancer: Are we up to the Challenge? Curr Genomics (2010) 1.21
Screening for colorectal cancer: established and emerging modalities. Nat Rev Gastroenterol Hepatol (2011) 0.99
Immunogenicity of autoantigens. BMC Genomics (2011) 0.97
Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity. Front Immunol (2015) 0.96
Development of a multiplex autoantibody test for detection of lung cancer. PLoS One (2014) 0.91
Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer. J Transl Med (2015) 0.82
Autoantibody signature differentiates Wilms tumor patients from neuroblastoma patients. PLoS One (2011) 0.79
Measuring the effect of inter-study variability on estimating prediction error. PLoS One (2014) 0.79
Systems approaches to molecular cancer diagnostics. Discov Med (2010) 0.76
Myasthenia gravis: analysis of serum autoantibody reactivities to 1827 potential human autoantigens by protein macroarrays. PLoS One (2013) 0.75
Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia. PLoS One (2015) 0.75
Serum tumor-associated autoantibodies as diagnostic biomarkers for lung cancer: A systematic review and meta-analysis. PLoS One (2017) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Characterizing the cancer genome in lung adenocarcinoma. Nature (2007) 16.48
Antibody pharmacokinetics and pharmacodynamics. J Pharm Sci (2004) 4.28
CT screening for lung cancer: update 2007. Oncologist (2008) 2.89
Treatment of non-small cell lung cancer stage I and stage II: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 2.60
Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2004) 2.53
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res (2001) 2.50
Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner. Br J Cancer (2001) 2.46
High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci U S A (2007) 2.10
A method for global protein expression and antibody screening on high-density filters of an arrayed cDNA library. Nucleic Acids Res (1998) 2.01
A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax (2008) 2.01
Panel of serum biomarkers for the diagnosis of lung cancer. J Clin Oncol (2007) 1.86
An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer. Proc Natl Acad Sci U S A (2001) 1.85
Profiling tumor-associated antibodies for early detection of non-small cell lung cancer. J Thorac Oncol (2006) 1.75
Autoantibodies in lung cancer: possibilities for early detection and subsequent cure. Thorax (2007) 1.73
Medicine. A bruising battle over lung scans. Science (2008) 1.59
Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci U S A (2005) 1.56
Lung cancer risk prediction: a tool for early detection. Int J Cancer (2007) 1.51
Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Cancer Lett (2005) 1.25
Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Res (2001) 1.24
Proteomics-based identification of alpha-enolase as a tumor antigen in non-small lung cancer. Cancer Sci (2007) 1.17
Using protein microarray as a diagnostic assay for non-small cell lung cancer. Am J Respir Crit Care Med (2005) 1.13
Novel autoantigens immunogenic in COPD patients. Respir Res (2009) 1.01
Toward an early diagnosis of lung cancer: an autoantibody signature for squamous cell lung carcinoma. Int J Cancer (2008) 0.92
Detection of auto-antibodies against L-myc oncogene products in sera from lung cancer patients. Int J Cancer (1996) 0.91
HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization. Diagn Mol Pathol (2003) 0.89
Unbalanced translocation, a major chromosome alteration causing loss of heterozygosity in human lung cancer. Oncogene (2008) 0.89
Update in screening of lung cancer. Respirology (2005) 0.85
Circulating antibodies to p40(AIS) in the sera of respiratory tract cancer patients. Int J Cancer (2000) 0.77
Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell (2012) 11.69
Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer. Sci Transl Med (2010) 6.39
Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet (2012) 5.28
GeneTrail--advanced gene set enrichment analysis. Nucleic Acids Res (2007) 5.10
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. J Clin Invest (2009) 5.07
Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer. Cancer Discov (2011) 4.80
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations. N Engl J Med (2015) 4.78
Recombination: Multiply infected spleen cells in HIV patients. Nature (2002) 4.38
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
New insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencing. Nat Commun (2012) 3.18
BNDB - the Biochemical Network Database. BMC Bioinformatics (2007) 2.75
High-fidelity gene synthesis by retrieval of sequence-verified DNA identified using high-throughput pyrosequencing. Nat Biotechnol (2010) 2.68
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial. Lancet Oncol (2011) 2.57
Targeted next-generation sequencing for the molecular genetic diagnostics of cardiomyopathies. Circ Cardiovasc Genet (2011) 2.45
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One (2009) 2.14
Toward the blood-borne miRNome of human diseases. Nat Methods (2011) 2.14
Early prediction of nonprogression in advanced non-small-cell lung cancer treated with erlotinib by using [(18)F]fluorodeoxyglucose and [(18)F]fluorothymidine positron emission tomography. J Clin Oncol (2011) 2.10
Intrahepatic IL-8 producing Foxp3⁺CD4⁺ regulatory T cells and fibrogenesis in chronic hepatitis C. J Hepatol (2013) 2.03
New non-viral method for gene transfer into primary cells. Methods (2004) 2.00
A blood based 12-miRNA signature of Alzheimer disease patients. Genome Biol (2013) 1.99
MicroRNA signatures in total peripheral blood as novel biomarkers for acute myocardial infarction. Basic Res Cardiol (2010) 1.87
Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies. Gastroenterology (2013) 1.83
GeneTrailExpress: a web-based pipeline for the statistical evaluation of microarray experiments. BMC Bioinformatics (2008) 1.77
Vandetanib plus pemetrexed for the second-line treatment of advanced non-small-cell lung cancer: a randomized, double-blind phase III trial. J Clin Oncol (2011) 1.75
CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2). J Virol (2005) 1.72
Indications and results of completion pneumonectomy. Eur J Cardiothorac Surg (2004) 1.68
Benchmarking of mutation diagnostics in clinical lung cancer specimens. PLoS One (2011) 1.65
Lessons learned from lung cancer genomics: the emerging concept of individualized diagnostics and treatment. J Clin Oncol (2013) 1.65
Multivariate miRNA signatures as biomarkers for non-ischaemic systolic heart failure. Eur Heart J (2013) 1.65
Activity-dependent plasticity in an olfactory circuit. Neuron (2007) 1.63
miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer (2009) 1.61
Matrix metalloproteinase 1 (MMP1) is associated with early-onset lung cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.58
A specific miRNA signature in the peripheral blood of glioblastoma patients. J Neurochem (2011) 1.58
GraBCas: a bioinformatics tool for score-based prediction of Caspase- and Granzyme B-cleavage sites in protein sequences. Nucleic Acids Res (2005) 1.57
Early palliative care for patients with advanced cancer: how to make it work? Curr Opin Oncol (2013) 1.57
Complex humoral immune response against a benign tumor: frequent antibody response against specific antigens as diagnostic targets. Proc Natl Acad Sci U S A (2005) 1.56
A novel tumor necrosis factor-mediated mechanism of direct epithelial sodium channel activation. Am J Respir Crit Care Med (2014) 1.55
A dictionary on microRNAs and their putative target pathways. Nucleic Acids Res (2010) 1.54
Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction. Basic Res Cardiol (2008) 1.52
Superior vena cava syndrome in thoracic malignancies. Respir Care (2011) 1.52
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer. Mod Pathol (2012) 1.50
Determinants and patient-reported long-term outcomes of physician empathy in oncology: a structural equation modelling approach. Patient Educ Couns (2007) 1.46
High-resolution transcriptome of human macrophages. PLoS One (2012) 1.42
Computation of significance scores of unweighted Gene Set Enrichment Analyses. BMC Bioinformatics (2007) 1.41
Diverse odor-conditioned memories require uniquely timed dorsal paired medial neuron output. Neuron (2004) 1.41
Tumor VEGF:VEGFR2 autocrine feed-forward loop triggers angiogenesis in lung cancer. J Clin Invest (2013) 1.41
Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer (2003) 1.41
Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. Lung Cancer (2011) 1.38
Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36
High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer (2010) 1.32
Deciphering the porcine intestinal microRNA transcriptome. BMC Genomics (2010) 1.30
A combinatorial approach to protein docking with flexible side chains. J Comput Biol (2002) 1.29
Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project. BMC Genomics (2008) 1.29
MicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumors. PLoS One (2012) 1.27
Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets (2009) 1.26
A novel gene from the human endogenous retrovirus K expressed in transformed cells. Clin Cancer Res (2002) 1.26
Alterations in cardiac DNA methylation in human dilated cardiomyopathy. EMBO Mol Med (2013) 1.23
Genome-wide miRNA signatures of human longevity. Aging Cell (2012) 1.21
CD74-NRG1 fusions in lung adenocarcinoma. Cancer Discov (2014) 1.19
Keratin 1 maintains skin integrity and participates in an inflammatory network in skin through interleukin-18. J Cell Sci (2012) 1.18
In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells. Cancer Biol Ther (2007) 1.18
Cell-autonomous and non-cell-autonomous mechanisms of transformation by amplified FGFR1 in lung cancer. Cancer Discov (2013) 1.18
The MLL fusion partner AF10 binds GAS41, a protein that interacts with the human SWI/SNF complex. Blood (2002) 1.17
A novel algorithm for detecting differentially regulated paths based on gene set enrichment analysis. Bioinformatics (2009) 1.17
Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing. Mult Scler (2013) 1.16
Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol (2011) 1.16
Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET). PLoS One (2008) 1.16